These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 11445851)
1. Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. Park YK; Park HR; Chi SG; Ushigome S; Unni KK Int J Oncol; 2001 Aug; 19(2):353-7. PubMed ID: 11445851 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma. Park YK; Park HR; Chi SG; Kim CJ; Sohn KR; Koh JS; Kim CW; Yang WI; Ro JY; Ahn KW; Joo M; Kim YW; Lee J; Yang MH; Unni KK Oncol Rep; 2000; 7(5):1041-7. PubMed ID: 10948336 [TBL] [Abstract][Full Text] [Related]
3. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis. Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773 [TBL] [Abstract][Full Text] [Related]
5. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603 [TBL] [Abstract][Full Text] [Related]
6. Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma. Park YK; Cho CH; Chi SG; Han CS; Ushigome S; Unni KK Int J Oncol; 2001 Oct; 19(4):749-53. PubMed ID: 11562750 [TBL] [Abstract][Full Text] [Related]
8. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Visscher DW; Sarkar FH; Shimoyama RK; Crissman JD Diagn Mol Pathol; 1996 Sep; 5(3):187-93. PubMed ID: 8866232 [TBL] [Abstract][Full Text] [Related]
9. p53 mutation is infrequent in clear cell carcinoma of the ovary. Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858 [TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy. Incognito LS; Cazares LH; Schellhammer PF; Kuban DA; Van Dyk EO; Moriarty RP; Wright GL; Somers KD Int J Oncol; 2000 Oct; 17(4):761-9. PubMed ID: 10995889 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
13. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994 [TBL] [Abstract][Full Text] [Related]
14. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163 [TBL] [Abstract][Full Text] [Related]
15. p53 mutations and expression in breast carcinoma in situ. Lukas J; Niu N; Press MF Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666 [TBL] [Abstract][Full Text] [Related]
16. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
17. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974 [TBL] [Abstract][Full Text] [Related]
18. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Waggoner SE; Anderson SM; Luce MC; Takahashi H; Boyd J Gynecol Oncol; 1996 Mar; 60(3):339-44. PubMed ID: 8774636 [TBL] [Abstract][Full Text] [Related]
19. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Grote HJ; Schneider-Stock R; Neumann W; Roessner A Virchows Arch; 2000 May; 436(5):494-7. PubMed ID: 10881744 [TBL] [Abstract][Full Text] [Related]
20. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]